Insider Trading & Ownership of Ted W. Love

Location
South San Francisco, CA
Summary
The estimated net worth of Ted W. Love is at least $3,860,748 dollars as of 02 Mar 2026. Ted W. Love is the Director of Royalty Pharma plc and owns shares of Royalty Pharma plc (RPRX) stock worth about $3.12M. Ted W. Love is the Director of GILEAD SCIENCES, INC. and owns shares of GILEAD SCIENCES, INC. (GILD) stock worth about $449.5K. Ted W. Love is the Director of Jazz Pharmaceuticals plc and owns shares of Jazz Pharmaceuticals plc (JAZZ) stock worth about $293.2K.
Signature
By: /s/Paz Dizon, as attorney in fact For: Ted W. Love
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Ted W. Love and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Sign up to save research and follow filings

Quick Takeaways

  • Ted W. Love has 6 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $3,860,748.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Royalty Pharma plc ($3,118,018).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Ted W. Love

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RPRX Royalty Pharma plc Director $3,118,018 13 May 2025
GILD GILEAD SCIENCES, INC. Director $449,546 07 May 2025
JAZZ Jazz Pharmaceuticals plc Director $293,184 26 Feb 2026
GBT Global Blood Therapeutics, Inc. President and CEO, Director 05 Oct 2022
SGEN Seagen Inc. Director 14 Dec 2023
GPCR Structure Therapeutics Inc. Director 23 Jun 2025

Insider Transactions Reported by Ted W. Love:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .